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Plain English summary
There are new ways to engage people with science and research but many patient support groups and charitable
organisations still hold traditional meetings to provide updates on their activities and to report new developments
in their field of interest. These meetings often feature presentations given by medical doctors or, in the case of
research-focussed organisations, by research scientists.
Receiving feedback from people who are confused and sometimes upset by some types of information, and the
way it is presented at meetings, made us think about better ways for researchers to discuss their ideas for new
research, or share the findings from completed projects, with patients and members of the public.
This article describes a method of public engagement called “Meet the Researchers” that enables people to hear
about current trends in research face to face with the researchers planning or conducting it. “Meet the Researchers”
is designed to promote discussion and allow questions to be asked in a relaxed and informal way, in small groups,
which is less daunting than asking questions in front of a conference audience. The aim is to break down the
barriers between researchers and patients, and enable conversations that will lead to meaningful engagement and
a better understanding of research. Additionally we aim to improve understanding of how results are passed on to
doctors and nurses and translated into improvements in patient care.
The method was tested with patients and was rated very highly by them in the feedback they gave.
Abstract
Background Innovative approaches to engaging people with science exist but are often framed around interactive
events or social media technologies. Notwithstanding the availability of novel approaches, many patient support
groups and charitable organisations continue to hold traditional meetings and seminars to provide information and
updates on their activities, and report on developments in their field of interest. In the case of research-focussed
organisations, these meetings often take the form of presentations delivered by clinical experts or research
scientists.
Observation of mesothelioma patients, their relatives, friends and carers attending scientific or clinical-themed
meetings has shown that they can be confused, and sometimes distressed, by presentations. This can be due to
didactic presentations that are not properly targeted to this audience and a lack of a general overview or summary
at the end of meetings that would provide some simple take home messages. This experience motivated the
development of a less formal method of sharing complex information and ideas in a simplified manner. “Meet the
Researchers” aims to make researchers accessible to patients in order to raise awareness and understanding of
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research and to explain how research translates into, and informs practice. This approach encourages the use of
plain English, removes the tendency to rely on PowerPoint slides to convey the message and moreover, provides
an opportunity for researchers to hear patients’ views.
Methods Small groups of participants met face to face with the researchers planning or conducting research
into their condition, and discussed the topics in a relaxed and informal way. The researchers spent a minimum of
20-min with each group before moving on to the next. Info-graphics on a portable device or printed hand-outs in
plain English were allowed but no formal presentations were made.
Results Our method has been evaluated using feedback data from three annual events held from 2016 to 2018:
100% of participants indicated that they liked the format “very much”(76.0%) or “quite a lot”(24.0%); 80.4% found
the topics “very interesting” and 75.9% found it “very easy” to ask questions. Free text comments revealed themes
of ‘hope’ and ‘altruism’. Researchers also reported benefits from participation such as learning about patient’
priorities and networking.
Conclusion “Meet the Researchers” provides a unique opportunity for mesothelioma researchers and patients,
relatives and carers to interact on a more equal footing. It stimulates discussion, promotes understanding and
provides a more informal setting for non-professional participants to ask questions. It is a format that could easily
be adapted for use in other conditions.
Keywords: Patient and public engagement, Methods of engagement, Evaluation, Mesothelioma
Background
Mesothelioma is an asbestos-related cancer, usually but
not exclusively, caused by occupational exposure. It is
classified as a rare disease, and it is recognised that
patients with rare diseases can be important partners in
research [1]. Mesothelioma has a long latency period
and is usually diagnosed when the patient becomes
symptomatic; at this stage treatment options are limited,
and prognosis can be short, hence the psychological
burden of the disease is high. These factors limit the
willingness and the capability of patients to become ac-
tively involved in research. Building a research portfolio
that reflects the needs and aspirations of mesothelioma
patients can therefore be challenging.
Framing the context of engagement
Defining “patient engagement” is not straightforward; the
literature on the topic is extensive but muddled because
the terms “involvement” and “engagement” are used inter-
changeably. A qualitative study and systematic review con-
cluded that while common concepts existed, the lack of
clear terminology and definitions create ambiguity and
confusion among stakeholders when referring to patient
engagement [2]. Angela Coulter’s widely used definition of
engagement focuses on the relationship between patients
and health care providers working together to “promote
and support active patient and public involvement in
health and healthcare and to strengthen their influence on
healthcare decisions, at both the individual and collective
levels.” [3] For the purpose of this paper, and because our
focus is on patient engagement with research, we have
chosen to adopt the definitions proposed by INVOLVE [4]:
“Patient engagement is where information and
knowledge about research is provided and
disseminated.”
This is distinct from their definition of involvement:
“Where members of the public are actively involved in
research projects and in research organisations.”
Innovative approaches to engaging people with science
are often framed around technology or social media; for
example the #whywedoresearch campaign [5]. Many mu-
seums, art galleries and other special-interest centres have
interactive displays and activity centres where people can
see how things work and try experiments for themselves
or practice their own creative skills. Additionally, the
Velindre Cancer Centre in Cardiff [6] and other NHS or-
ganisations organise laboratory visits in conjunction with
charities like Cancer Research UK [7] and Cancer Re-
search Wales [8]. Science and research roadshows are also
popular and just three examples of successful approaches
are as follow: Southampton University’s Roadshow [9], the
CHaOS Roadshow [10] and the National Institute of
Health Research “I am Research” event [11]. Closer to the
method we describe in this paper (but not identical) is the
National Cancer Research Institute’s “Meet the Expert”
session [12], which is held at their annual conference.
These are informal sessions during which attendees have
an opportunity to meet an eminent researcher in their
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field (typically a plenary speaker presenting at the Con-
ference) and ask questions.
Notwithstanding these novel approaches, many patient
support groups and charitable organisations continue to
hold traditional meetings and seminars to provide infor-
mation and updates on their activities and report on
developments in their field of interest. In the case of
research-focussed organisations, these meetings often
take the form of presentations delivered by clinical experts
or research scientists. Improving methods of engagement
with researchers is a first step towards developing partner-
ship in priority setting and coproduction of research [13]
but evidence for the best way of achieving it is scant [14].
In this methodological paper we describe a successful
approach to patient engagement with research in meso-
thelioma. The aims of this method of patient engage-
ment were threefold:
1. To provide information about research in lay terms
(Researcher to Patient)
2. To break down barriers, and provide an informal
question time for patients and carers
3. To provide feedback (Patients to Researchers) about
their perception of research and areas of research
needs.
An evaluation of the method is also reported based on
the feedback received from patients, relatives and profes-
sionals attending the last three such annual charity
events.
Methods
The “Meet the Researchers” concept is a fusion of
speed-dating (where a group of singles meet for a fleeting
date with each other, typically of 3 to 4 min duration) and
the Dragon’s Den (a popular TV series in which budding
entrepreneurs present their ideas to a panel of investors).
The idea was driven by observations of patients’ at con-
ventional meetings, and the need to move away from a
format in which professionals ‘address’ the audience, and
create an environment more conducive to disseminating
information through discourse and questions. “Meet the
Researchers” was designed to offer participants the oppor-
tunity to hear about current trends in research in small
groups, face to face with the researchers planning or con-
ducting it, and enable a discussion to flow in a relaxed and
informal way. The aim was to make researchers accessible
to patients in order to raise awareness and understanding
of research and to explain how research informs and
translates into practice.
The “Meet the Researchers” format was first enacted in
a mesothelioma patient group at the June Hancock Meso-
thelioma Research Fund (JHMRF) Action Mesothelioma
Day Event in Leeds in 2011 [15]. Action Mesothelioma
Day is a national event that takes place annually on the
first Friday of July. Mesothelioma charities, as well as local
asbestos and mesothelioma support groups, organise pub-
lic meetings in different locations. The JHMRF is a charity
that relies solely on donations from the public. It is run by
volunteers and has no paid employees. The JHMRF Action
Mesothelioma Day “Meet the Researchers” event is the
charity’s annual public facing event; it is free to attend.
Lunch and refreshments are provided but participants are
not reimbursed for attending. Participants include meso-
thelioma patients, their friends and relatives; bereaved
relatives; representatives from other local cancer support
groups, healthcare and legal professionals. A breakdown
of participants who completed feedback forms in the three
years from 2016 to 2018 is shown in Table 1.
A large room with circulation space was used and laid
out in cabaret format: circular tables of 8 to 10 (see
Fig. 1). The tables were numbered (1 to n) and two spare
seats were provided at each table. Patient participants
were asked not to change tables during the day. A short
introduction was given to brief participants about the
research groups attending, and how the meeting would
be conducted.
The researchers were allowed a minimum of 20-min
at each table (timing can be flexible depending on the
meeting schedule but it is important to allow time for
breaks, ideally after each round of no more than three
table sessions, and for summing up at the end). Each
research group (1 or 2 representatives) was asked to pre-
pare a brief introduction for a non-professional audience
that could be delivered in a maximum of 5-min. This
was the ‘Dragon’s Den’ pitch, which outlined research
interests or a specific research project; the remainder of
the table session (15-min) was open for the ‘speed-dat-
ing’ questions from the table (see Fig. 2). Aids to under-
standing in the form of infographics or printed handouts
in plain English were permitted, and a tablet or lap-top
could be used to show one or two pictures, graphs or di-
agrams either as part of the opening pitch or to illustrate
points raised in the ensuing discussion.
The research groups moved sequentially from table to
table. Group 1 started at Table 1 and progressed round
the remaining tables to finish at Table 8; Group 2 started
at Table 2 and moved round to finish at Table 1 and so
on. Flexibility is required in forming research groups
Table 1 Participants’ profile 2016–2018
Participant Groups* 2016 2017 2018 Total
Patients 14 8 17 39
Relatives/carers/ bereaved relatives 18 14 16 48
Healthcare and other professionals 8 2 5 15
Total providing feedback 40 24 38 102
Percentage of total attendees 47.6% 35.8% 51.4% 45.3%
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and tables depending upon the number of attendees,
and availability of researchers. The options for group
configuration are either by specific project groups or by
research discipline. Table 2 shows the research groups
participating in Action Mesothelioma Day 2017 as an
example of the areas covered.
Table moderation is the role of the facilitator assigned
to each table; this is a key role (suitable for a Trustee or
charity associate with the right skill set). The facilitator
assists with time keeping and eliciting or moderating the
questions. They also keep notes for the summing up at
the end of the event, although another person can be
nominated by the table members to deliver the feedback.
Three to five minutes before each table session ended,
an amber warning card was shown to allow groups to
wind down the discussion. At 20-min an audible warn-
ing and red card signalled time to move on to the next
table. It is very important to keep to time; if a discussion
was unfinished or questions unanswered the table facili-
tator noted them so that unresolved issues could be
dealt with in the breaks or during the summing up ses-
sion. The research groups are required to move on to
the next table to avoid disrupting the flow and delaying
the schedule. It is also important to encourage attendees
to remain with the same table group throughout the




The JHMRF has used the “Meet the Researchers” format
successfully for annual Action Mesothelioma Day events
from 2011 to the present. Feedback has been evaluated
using two types of data: quantitative descriptive statistics
derived from a standard questionnaire, and qualitative
comments derived from the free text sections of the
questionnaire and from email messages, texts and thank
you letters sent by participants after the event.
The “Meet the Researchers” format has proved to be
extremely popular with people attending Action Meso-
thelioma Day events compared to previous events (held
from 2008 to 2011), that used a traditional format featur-
ing invited speakers and formal presentations. We ac-
knowledge that feedback data is generally skewed to the
positive but feedback for “Meet the Researcher” events
has been much improved both in terms of the number of
forms completed, and the number and content of com-
ments. Combining data from 2011 to 2018, the proportion
of feedback forms completed by attendees (n = 379) was
42.0%, of which about a third were patients and more than
half were relatives and carers. Less than 10.0% of partici-
pants provided feedback in the years preceding 2011.
We aggregated our feedback data for the years 2016 and
2018. Rated on a four-point categorical scale: “not at all”; “a
little”; “quite a lot” and “very much”, 76.0% of respondents
liked the format “very much” and 24.0% liked it “quite a lot”.
On a similar scale, 80.4% of respondents rated the topics cov-
ered as “very interesting”. The question relating to presenta-
tion of information proved more discriminating and
indicates that, although the majority of respondents found
the information presented “very clear and easy to under-
stand” (65.3%) or “quite easy” (25.3%), some still struggled:
8.4% of respondents rated the information they received as
“moderately easy to understand” and one respondent found
it “not at all easy to understand”. This finding supports the
evidence on which the “Meet the Researchers” model is
predicated: that giving information about research to patients
and carers cannot be construed as a simple and straightfor-
ward undertaking. Nevertheless, 75.9% of respondents found
it “very easy” to ask the questions they wanted to ask, and
this is reassuring as it suggests that the “Meet the Re-
searchers” format does indeed facilitate interactive discussion
and enables participants to ask questions more easily.
Fig. 1 Room Layout
Fig. 2 Table session in progress
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Feedback from JHMRF Action Mesothelioma Day
events held before 2011 focussed on practical aspects of
the meeting like the venue and catering. Consequently
suitable data from the events we held using a traditional
format is not available to compare with our feedback
from subsequent “Meet the Researchers” events.
Qualitative data
Space was provided on the feedback forms for respon-
dents to enter any comments about the day. While not
everyone took the opportunity to express their views, a
surprising number of comments were received on the
forms and many verbal comments were made to, and
noted by, table facilitators. Many thank you letters, text
and email messages were also received after the meet-
ings. The comments from all years were collated and
three broad categories emerged:
1. Practical aspects of the meeting
2. The Future
3. Information
Practical aspects of the meeting
Problems experienced at the meetings, expression of
thanks and appreciation, and suggestions for future
events were the themes associated with the practical
aspects of the meeting. Problems identified included
noise from adjacent tables, difficulty hearing and fatigue.
Noise, occurring as a result of many conversations tak-
ing place simultaneously, was a common complaint
across all years despite an attempt to address the prob-
lem by changing the venue for a larger room. Increasing
the distance between the tables, albeit at the expense of
some exhibition space, proved to be effective. We did
consider using breakout rooms but the short sessions
are not conducive to moving between rooms; moreover
the cost to the charity would be prohibitive as we would
need a room for each “table” of participants in addition
to a large room for the collective sessions.
Suggestions from participants for future events were
mostly practical hints and included allowing 5-min at the
end of each table session to confer among themselves
about points requiring further clarification or to formulate
additional questions for the summing up session.
The future
Within The Future category were themes of hope and
altruism linked with sentiments such as ‘helping others’
and ‘leaving a legacy’. Examples of comments included:
“Just being in front of a researcher gives me some hope
– if not for me, for others in the future” and “It’s great
to know that not everything is doom and gloom – that
there is hope - that research is going on and that our
input today may help researchers help mesothelioma
patients even more.”
Information
Information was a broad category within which many
cross-cutting themes emerged. Many respondents de-
scribed the day as “informative” or said that they “felt bet-
ter informed” but were not explicit about how they had
been informed; these comments were frequently linked to
expressions of thanks and appreciation. A few respon-
dents were more specific about the information they had
received, for example
“To be up close with the researchers was invaluable, to
know what is going on behind the scenes is reassuring.
Lovely, informal, informative day.”
“I found the talk on radiotherapy for the new planned
treatment for pain in meso patients very informative, and
the fact that it will be available at (hospital named) soon”.
At our most recent event we tried to tease out why
attendees felt better informed by specifically asking if
attendees had found the meeting useful, and
Table 2 Research Groups 2017
Group 1 Organic chemistry JHMRF PhD Fellowship: A structure-activity study of JBIR-23 to determine the components
required for activity against mesothelioma cell lines.
Group 2 Patient Research Ambassador Patient and Public Involvement in research
Group 3 Clinical research JHMRF funded project: SYSTEMS 2 A trial of radiotherapy for pain control in mesothelioma.
Group 4 Surgical research MARS2: A feasibility study comparing (Extended) Pleurectomy Decortication versus no
Pleurectomy Decortication in patients with mesothelioma. Funded by Cancer Research
UK and Papworth Hospital NHS Foundation Trust.
Group 5 Thoracic Oncology Immunotherapy of MPM by blockade of suppressor intratumoural Treg: target identification
Group 6 Cell Biology JHMRF PhD Fellowship: Understanding the pathogenesis of mesothelioma.
Group 7 Applied Research RADIOMESO: Receiving a diagnosis of mesothelioma: improving the patient experience.
Funded by Mesothelioma UK
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providing a free text space for them to comment on
this aspect. All respondents (100% in 2018) indicated
that they had found the meeting useful, and several
comments were received. The following extracts cap-
ture the three main categories that emerged from the
free text data:
“It gave information on subjects we find difficult.”
“Gave a deeper understanding of research.”
“Keeps me up to date with research and
developments.”
The professionals’ perspective
We asked our researchers for feedback on the method
too; some completed standard feedback forms while
others preferred to send comments by email after the
meeting. We found that “Meet the Researchers” posed
challenges for some researchers, especially for those who
had no patient-contact before or who had always used
formal PowerPoint presentations in the past. This new
format of meeting gave them the opportunity to de-
velop and practice their communication skills to a
largely non-professional audience, and it was perceived
as a positive experience. Nearly all cancer research grant
applications now request a plain English summary and
the Action Mesothelioma Day meeting is an ideal forum
to present ideas or results to a general audience. Meet-
ing the sufferers of the disease can also be a humbling
experience for those who are not clinical researchers. A
young laboratory scientist attending the event for the
first time commented:
“It was a very valuable experience for me. I've never
had any form of patient contact before so there was a
lot I took away from the day, and I had lots of
feedback to give our team…”
Another young clinical researcher commented:
“Today has be a salutary reminder of why we do
research and who for….”
Even more experienced researchers felt the event was
worthwhile, a research group leader commented after
the first event in 2011:
“It was a very interesting new format as neither of
us has been at a “speed dating” before! ...It worked
extremely well, as people who otherwise would not
have asked any questions were more confident in a
small group setting to actively participate.”
Another commented that it was
“A worthwhile and educational experience for all”.
The informal nature of the meeting also facilitates inter-
action and informal talks between participating scien-
tists, working on wide-ranging aspects of mesothelioma.
A full evaluation report of the feedback from Action
Mesothelioma Day 2016 and 2017, including quantita-
tive data tables and a full list of free text comments, is
available on the JHMRF website [13].
Discussion
The challenge of patient engagement in mesothelioma
First-hand experience of the difficulties faced by re-
searchers in communicating complex research ideas and
results to patients with mesothelioma led us to reflect
on approaches to dissemination to this patient group.
Two examples, in particular, come to mind: first, watch-
ing patients bury their heads in their hands or become
tearful when presenters show (not very optimistic) sur-
vival curves, or describe symptoms like difficult pain and
breathlessness; and second, witnessing audiences in the
afternoon sessions of full-day events stare, silently and
glassy-eyed, at yet another presentation with numerous
slides showing complicated tables and images. The most
compelling observation, however, was an encounter with
a patient who left one of these meetings abruptly, saying:
“I’m sorry, I just have to escape – I can’t take any more
of this……it’s all doom and gloom.” This was a timely
and cogent incentive for us to think more creatively
about how we give patients information, especially those
with terminal conditions.
Patient engagement in research is now an essential re-
quirement for research grant applications to core fun-
ders like the National Institute for Health Research
(NIHR) [16] and the Medical Research Council (MRC)
[17]. INVOLVE was established in 1996 [18], funded by
the NIHR, to support active public involvement in NHS,
public health and social care research; and UK Research
and Innovation (UKRI) recently published a concordat for
patient engagement in 2018 [19]. As a research-funder,
the JHMRF is also keen to build a research portfolio that
incorporates the views, and reflects the needs, of meso-
thelioma patients and those close to them. Nevertheless,
involvement in research priority setting places a burden of
responsibility on predominantly lay people, with varying
levels of experience and preparedness for the role, at a
difficult time; and it is unrealistic to expect ordinary mem-
bers of the public to become consultants in research
design and collaborators in the process of the research; or
shapers of health care policy without helping them to
acquire the knowledge and skills they need to become ac-
tively and meaningfully involved. “Meet the Researchers”
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is designed to build rapport between patients and re-
searchers thereby creating opportunities for patients to
shape the JHMRF research agenda in a way that is less
demanding for them. By using the football analogy of red
and yellow cards, and the whistle to signal time, we aimed
to reduce the formality of the meeting and relax partici-
pants by adding a little fun to the event. The short, inter-
active sessions diminish meeting fatigue and allow
researchers and patients, relatives and carers to interact
on a more equal footing.
Methods of engagement
“Meet the Researcher” (or Meet the Experts) events are
held in other settings but typically these are themed
around a single expert or a panel of experts, speaking
with an audience [12, 20]. The NCRI’s Dragons’ Den
Workshop [21] is the closest methodological comparator
as it offers the opportunity for researchers to discuss
ideas with, or pitch research projects, to small panels of
patients, corresponding to our table sessions at our
“Meet the Researchers” event. The major difference is
that the NCRI Dragons’ Den is focussed on partnership,
problem-solving and co-production in relation to re-
search proposals. “Meet the Researchers” is not designed
to appraise research but aims to raise patients’ awareness
of research in mesothelioma and help them to under-
stand the way research is funded, conducted, reported
and eventually translated into practice. An unanticipated
outcome from our qualitative evaluation of the method
was the extent to which researchers reported learning
from the event. This supports the argument postulated
by Staley (2017) that we should rethink our definition
of impact when evaluating patient engagement and
involvement activities [22].
The “Meet the Researchers” method of engagement is
not limited exclusively to research. For example, if the
meeting focus is on care, “Meet the Experts” could be
conducted in a similar way with medical specialists, spe-
cialist nurses, allied healthcare professionals from differ-
ent disciplines or medico-legal experts forming the
expert groups. In this example, however, it is important
for the table facilitator to moderate the table conversa-
tions effectively, and prevent individual cases becoming
predominant. This was a problem we encountered when
we mixed research and clinical experts for our “Meet the
Experts” event in 2015.
Although we have not used our method for more tar-
geted patient involvement activities, we speculate that it
could also be applied to identify patients’ priorities for
research, or elicit patients’ views on study design when
planning a new project. A 2014 review by Brett et al.
reported that lack of preparation and training led some
service users to feel unable to contribute to the research,
while other service users and communities reported
feeling overburdened with the work involved. Researchers
reported difficulties in incorporating patient and public in-
volvement (PPI) in meaningful ways due to lack of money
and time [23]. “Meet the Researchers could potentially
overcome some of these difficulties by linking researchers
with a large number of patients, without the time or
expense of separate meetings or by replacing reviews of
lengthy, written research proposals with group discus-
sions, thereby reducing the workload for patients.
Limitations of the method and evaluation
There are some aspects of our method that require re-
finement; for example providing additional breaks dur-
ing the sessions to reduce fatigue (both patients and
experts) and managing the noise level, which we over-
came in 2018 by increasing the distance between the ta-
bles albeit at the expense of exhibition space for our
charity and our partners in the event. Feedback from all
participants also suggested that better briefing of re-
searchers and table facilitators is required to ensure that
information is presented, and questions are answered, in
a clear and accessible way. Moreover, feedback from our
2017 event indicated that a brief outline of researchers
and their field of expertise would be valued by both pro-
fessional and non-professional participants. This would
enable table facilitators and attendees to prepare ques-
tions, and researchers to cross-reference each other’s
work to link up discussions more effectively and not ap-
pear as isolated, unconnected examples coming from in-
dividual laboratories. This latter suggestion was
implemented at our most recent (2018) event and was
well received; evidenced by the fact that not a single
programme was left behind at the end of the meeting.
We acknowledge that our evaluation is constrained by
the nature of the data collected from feedback forms.
We also recognise that assessing the impact and benefit
of engagement activities for patients is difficult because
methods of evaluation are under-developed and evidence
is limited [24]. Reports of similar events are generally
found only in organisations’ newsletters and on their
websites; and our scoping review revealed only one pub-
lished paper reporting an evaluation of event feedback
[25]. This event (a national PPI day for thyroid eye dis-
ease) used a combination of approaches to engagement,
including didactic lectures, and focus group discussions.
Fifty-two percent of attendees at the event provided
feedback and of these respondents, 88% rated it very
good or excellent. This is comparable with the feedback
we received at our “Meet the Researchers” event but it is
not possible to comment on whether the combination of
lectures and focus groups is better than our informal
discussion-based approach due to the limitations of
feedback data. Options for wider comparison of our re-
sults are limited because reviews of patient engagement
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activities tend to focus on the impact, not the method,
of engagement on research or practice.
Conclusion
“Meet the Researchers” is a method of public engage-
ment that provides a unique opportunity for mesotheli-
oma researchers and patients, relatives and carers to
hear about current trends in research face to face with
the researchers planning or conducting it. The informal
approach breaks down the barriers between researchers
and patients and enables interaction on a more equal
footing, without the use of PowerPoint presentations
[26]. This reduces the impression that researchers are
“talking to” the participants and helps stimulate conver-
sations that lead to meaningful engagement, and a better
understanding of research.
Feedback from our Action Mesothelioma Days has
shown that participants felt empowered to ask questions
because they found it less daunting to speak in small
groups than they would in front of a conference audi-
ence. They also reported feeling better informed after
the event and, importantly, said they felt that their
experiences and opinions were valued. This is an en-
couraging outcome because being better informed and
feeling able to contribute are springboards to future in-
volvement [27]. Moreover, the participating researchers
said they had benefitted and this too has important
implications for facilitating future research collabora-
tions and co-production.
The practical details included in the paper will be use-
ful to the organisers of patient engagement events, par-
ticularly those seeking a new approach. The evaluation
of the feedback provides some insight into the applica-
tion of the method and how it is received by partici-
pants. The “Meet the Researchers” method could easily
be replicated or adapted for use in other conditions and
settings. It is also flexible and can focus on one theme or
cover a range of topics from basic science to clinical tri-
als and health services research. In this way, patients can
be supported to recognise the different types and stages
of research, and understand how results are passed on
to doctors and nurses and translated into improvements
in patient care.
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